|Mr. Chung Yuen Huen||Founder, Chairman & CEO||474.53k||N/A||1980|
|Mr. Darren Lui||Pres & Exec. Director||256.54k||N/A||1981|
|Ms. Sabrina Khan||CFO & Company Sec.||372.54k||N/A||1982|
|Dr. Clark Cheng||Chief Medical Officer & Exec. Director||465.26k||N/A||1980|
|Dr. Wai Yip Lee||Head of R&D||405.2k||N/A||1974|
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom.
Aptorum Group Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.